TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. - Wikidata - awgldk - TriplyDB

TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression.

TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression.

http://www.wikidata.org/entity/Q53652661

about

Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9 Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production Cellular immune response parameters that influence IgE sensitization Targeting the Fc receptor in autoimmune disease Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells Targeting allergen to Fc gammaRI: a strategy to treat allergic disease?BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function.The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations.Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells CD14, a key candidate gene associated with a specific immune response to cockroach Against all odds: anti-IgE for intrinsic asthma?Virus/allergen interactions and exacerbations of asthma.Dendritic cell and T cell responses in children with food allergy.Immune pathways for translating viral infection into chronic airway disease.Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy New immune pathways from chronic post-viral lung disease Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders.Pulmonary allergic responses augment interleukin-13 secretion by circulating basophils yet suppress interferon-alpha from plasmacytoid dendritic cells.Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype.Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge.Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia Dendritic cells, viruses, and the development of atopic disease.Decoding IgE Fc receptors.Increased IL-12 inhibits B cells' differentiation to germinal center cells and promotes differentiation to short-lived plasmablasts.Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells.Molecular pathogenesis and clinical implications of eczema herpeticum.Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease Expression of the high affinity IgE receptor by neutrophils of individuals with allergic asthma is both minimal and insensitive to regulation by serum IgE.New insights into the mechanism and management of allergic diseases: atopic dermatitis.Human skin and oral mucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses.Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.Regulation of effector and memory T-cell functions by type I interferon.IFN-λ and IgE-mediated allergic disease: a potential future role?Role of viruses in the development of atopic disease in pediatric patients Regulation of TLR7/9 signaling in plasmacytoid dendritic cells.Plasmacytoid Dendritic Cells: Neglected Regulators of the Immune Response to Staphylococcus aureus.The role of FcεRI expressed in dendritic cells and monocytes.Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study.

P2860

Q24651071-104A30D1-689D-4223-B7F9-677D77F32A02 Q24676710-C167744E-FB55-4DEA-8A66-2DF0887303B5 Q26823029-BFDFA7CC-23DE-4F24-8A08-A86021D972E6 Q27002843-01FF3BE8-7544-427D-B539-D064CB5027FF Q28280375-5B0FCFED-0B06-40ED-B1E9-5473C634E991 Q30437725-B2268F81-5C5D-4B34-AF38-31BF1B3D528E Q33298653-DF4EEE60-B437-49FB-8036-9A7A34CB2A5F Q33723523-26DB4782-AFAF-4646-A168-871931D14C2C Q33786076-9859BD6E-6176-4C08-906B-222B96C89E8D Q34055580-BA932D2F-10BC-46AF-A37D-C0CA3B0CB0B0 Q34063320-DBC44852-5E1F-44B1-928B-072DE32E6D01 Q34346950-AA00AC97-D5B1-4825-9C35-981627349332 Q34401905-D98080E9-F412-4954-B32B-6CD6CCA9DD2C Q34424827-1122E877-2AB8-4BD0-88D4-ADBB6269BF43 Q34440425-58A30D2A-23C9-41E6-B916-31F89F25AD86 Q34613611-1C7AAFFE-48B4-4870-8EFF-7A2787404D6C Q34692122-BB042D74-2A0E-45BF-B862-8DCCB0624E7B Q34993078-F7914E9F-FEB3-46C3-A9A8-29AD506CC294 Q35095071-020A9598-B747-4863-8B41-09317F1E04CD Q35660526-3A3B929F-879C-45A6-B061-C6C90A8B78F8 Q36176064-A2F75FAF-27C8-4C39-9E34-87D3DB8A9D30 Q36203174-A0FF08FF-BAA5-4F4C-94DF-B80DB854B449 Q36229077-D2908574-94F6-41D2-91E1-CF83C6D4F898 Q36340296-C8F6BA75-88BE-4CDC-8E50-F694692F0CB2 Q36818986-53C2CD6C-0C62-44C4-841D-628C5B5034F7 Q36916349-021AB61F-4BE4-40A2-B635-FD0A9E0EBBD2 Q37171962-B7F1FD18-F2C8-4C54-AF4C-558CEEA5BB9C Q37213870-25900BD8-0FE7-4C29-AC05-262568F511BE Q37245942-27066071-F47C-4D22-A71F-E1F4B9BF63DF Q37337010-C2EEFA9E-625F-4B59-AAD5-9B270A9E4CF2 Q37379963-521D4410-A2C5-41BC-BBF7-E576B783C2ED Q37735264-880193E2-D83C-4AB1-9147-116626BB3D58 Q37769441-591E5BF0-D86B-42F9-A8A6-5325891C03DC Q37841676-F22A45B2-3204-4655-86BC-F29767167900 Q37997043-D08EC049-7B86-4768-84B5-CA504D110CE2 Q38036585-311EDC0D-AC02-4EE2-82B4-EC46B894388D Q38058240-019031E8-9DFA-4144-AF2D-B2DECD20AEE5 Q38218117-B03D7993-8CC9-4B35-97D1-0AB5C2D9F656 Q38365223-DBB45291-B976-4F3D-B5D6-182B71033A33 Q38396322-2FCCDB72-A619-412B-BA25-E055A1909FEE

P2860

TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression.

http://www.wikidata.org/entity/Q53652661

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@en

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@nl

type

label

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@en

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@nl

prefLabel

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@en

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@nl

P1433

Q53652661-356BE441-A7A5-45B3-A4E1-35F1BA1CDA78

P1476

Q53652661-7A482E93-F5AB-46FF-A4F8-F223C6988A58

P2093

Q53652661-03488AD1-579F-4655-8A6E-AA21C627FB5E

Q53652661-21C46E05-1288-4F10-9D08-5DA800AFE48C

Q53652661-299005F8-760F-4C8D-ADBE-8364C94E8D1C

Q53652661-8DC89CC4-B1B1-4D16-B0A5-DE4581235531

Q53652661-AC0E70FD-E925-4938-8652-B7A38857FFC6

Q53652661-DF676FD8-7D23-4741-87F4-B2AAF7311B3D

Q53652661-E5B631EE-29A7-45FF-8B11-60EA6B1B1CD5

P304

Q53652661-16F91E4A-C4B0-441B-89A0-5713B91B9614

P31

Q53652661-F1C64F97-9640-4774-98FB-B43FD05EF3A0

P356

Q53652661-339E713B-6BEA-41C7-9B49-66354F02FB25

P407

Q53652661-F867FC38-0B58-4181-A67E-2B420A9D64BE

P433

Q53652661-62A3EC3E-56CB-45D0-B9F1-99B3AFF4F393

P478

Q53652661-6CE8C4D3-5BA9-4C60-BE05-ECD192FFDFD4

P577

Q53652661-1A4F25A1-C615-4E3C-B8DB-892D9DC85E45

P5875

Q53652661-9285670E-BBB1-4454-825F-A107008923AD

P698

Q53652661-7592A707-6D35-4D5A-80DD-E7C695E74B24

P921

Q53652661-FD4D0694-7999-467C-81D6-71536D2E188E

P356

JIMMUNOL.175.9.5724

P1433

Journal of Immunology

P1476

TLR9- and FcepsilonRI-mediated ...... egulating receptor expression.

@en

P2093

Anja P Bieneman

http://www.w3.org/2001/XMLSchema#string

Huiqing Xiao

http://www.w3.org/2001/XMLSchema#string

John T Schroeder

http://www.w3.org/2001/XMLSchema#string

Kavitha Vasagar

http://www.w3.org/2001/XMLSchema#string

Kristin L Chichester

http://www.w3.org/2001/XMLSchema#string

Mark C Liu

http://www.w3.org/2001/XMLSchema#string

Sarbjit Saini

http://www.w3.org/2001/XMLSchema#string

P304

5724-5731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.175.9.5724

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7529576

http://www.w3.org/2001/XMLSchema#string

P698

16237063

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor